-
Signature
-
/s/ Avraham S. Adler, Attorney-in-Fact
-
Stock symbol
-
PTCT
-
Transactions as of
-
Sep 11, 2025
-
Transactions value $
-
-$649,399
-
Form type
-
4
-
Date filed
-
9/16/2025, 05:00 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Reeve Emma |
Director |
C/O PTC THERAPEUTICS, INC., 500 WARREN CORPORATE CENTER DRIVE, WARREN |
/s/ Avraham S. Adler, Attorney-in-Fact |
2025-09-16 |
0001680329 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PTCT |
Common Stock |
Sale |
-$210K |
-3.53K |
-23.25% |
$59.50 |
11.7K |
Sep 11, 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
-$79.4K |
-1.33K |
-11.43% |
$59.50 |
10.3K |
Sep 11, 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$257K |
+10K |
+96.79% |
$25.69 |
20.3K |
Sep 11, 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
-$595K |
-10K |
-49.18% |
$59.50 |
10.3K |
Sep 11, 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Options Exercise |
$28.1K |
+837 |
+8.1% |
$33.63 |
11.2K |
Sep 11, 2025 |
Direct |
F1 |
| transaction |
PTCT |
Common Stock |
Sale |
-$49.8K |
-837 |
-7.49% |
$59.50 |
10.3K |
Sep 11, 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-10K |
-100% |
$0.00 |
0 |
Sep 11, 2025 |
Common Stock |
10K |
$25.69 |
Direct |
F1, F2 |
| transaction |
PTCT |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-837 |
-100% |
$0.00 |
0 |
Sep 11, 2025 |
Common Stock |
837 |
$33.63 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: